Jingjing Song
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
TRIM32 drives head and neck squamous cell carcinoma progression via TP53 suppression and lysosomal/autophagy dysregulation.
Journal: Translational cancer research
Published: April 10, 2026
Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response.
Journal: Annals of medicine
Published: October 10, 2024
Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CT.
Journal: EJNMMI research
Published: June 04, 2024
Intense 18 F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18 F-FDG PET/CT.
Journal: Clinical nuclear medicine
Published: April 03, 2024
Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats.
Journal: Respiratory research
Published: February 07, 2024
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Journal: Frontiers in immunology
Published: October 06, 2022
Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 13, 2022
The impacts of particle size on starch structural characteristics and oil-binding ability of rice flour subjected to dry heating treatment.
Journal: Carbohydrate polymers
Published: May 08, 2019
Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 26, 2018
Mesenchymal stem cells participate in oral mucosa carcinogenesis by regulating T cell proliferation.
Mesenchymal stem cells participate in oral mucosa carcinogenesis by regulating T cell proliferation.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 17, 2018
Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells.
Journal: Cancer immunology research
Published: March 07, 2018
Last Updated: 09/26/2026